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Abstract
Objective
Assess changes in prescribing practices in the adolescent population after common knee
surgeries in light of the enactment of Pennsylvania Opioid Prescribing Law Act 125.
Methods
An analysis of postoperative opioid morphine milligram equivalents (MMEs), number of
opioid pills, and total milligram dosages of nonsteroidal anti-inflammatory drugs (NSAIDS)
prescribed to adolescents after common knee surgeries was performed. An analysis
comparing MMEs to the number of opioid pills prescribed to patients specifically undergoing
anterior cruciate ligament (ACL) surgery was also conducted.
Results
There was a statistically significant decrease in the number of opioid pills and MMEs
prescribed postoperatively in 2017 compared to 2014. There was a statistically significant
increase in the number of opioid pills prescribed and MMEs postoperatively for those who
received a femoral nerve catheter compared to those who did not receive a femoral nerve
catheter in 2017.
Conclusion
While there is a general trend that fewer opioid pills and more NSAIDs are being prescribed
postoperatively, lowering MMEs, when comparing data from 2014 to 2017, doctors
prescribed more postoperative opioid pills for patients who received femoral peripheral nerve
catheters, than those who did not receive femoral peripheral nerve catheters.
Key Words: Opioid epidemic, narcotics, adolescent addiction, non-prescription opioid abuse,
opioid prescribing pattern.
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Introduction
The Centers for Disease Control and Prevention (CDC) declared an opioid epidemic
in the United States in 2011, one that affects Americans of all races, ethnicities, and
socioeconomic statuses.1 Rudd et al reported that from 2000-2014 more than 500,000 people
in the United States died due to overdosing and that 61% (305,000) of these overdoses were
due to opioid drugs alone.2 Oxycodone and hydrocodone were the most common drugs
related to these overdoses and are also the most common drugs prescribed for postoperative
pain. Rudd et al also reported that the number of prescriptions for opioid medications have
quadrupled since 1999.2

Additionally, the economic burden of this epidemic is growing, costing the United
States more than $78.5 billion dollars annually, and public sources pay for nearly 25% of it.3
According to Taylor et al., the opioid crisis is largely due to a long history of poorly managed
prescription practices in healthcare.4

But opioid abuse is not the only consequence of liberal opioid prescription practices:
there has also been a similar increase in heroin abuse. Compton et al estimated that while
only 4% of those who misuse prescription opioids move on to heroin use, 70% of those who
use heroin started off misusing prescription opioids.5 They also reported that heroin use since
2007 has increased by over 145% and that deaths from heroin overdose have more than
quintupled.5 Thus, the abuse of both heroin and prescription opioids have grown in parallel
and at an alarming rate in the past decade, with the increase in the former largely due to
heroin being a more potent, less expensive, and more easily acquired opioid compared to
other drugs within the same class.5 And while heroin is an opioid with unique chemical
components, it affects the brain receptors the same way as prescription opioids; this leads a
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certain percentage of the population, then, to switch from one source of opioid to another.
The similar way in which heroin affects the brain, in conjunction with its low price, therefore
makes prescription opioids a driving factor for heroin abuse.5

The pediatric population, specifically young teens from the ages of 13 through
17, also suffer with opioid abuse, yet the medical literature does not report on this
epidemic as robustly as it does for adults. Allen et al6 examined data from poison control
centers in the United States and found that adolescents had the second highest rate of opioid
exposures and the greatest number of intentional opioid exposures. Furthermore, Allen et al’s
work supports previous research which found that the adolescent population was the only age
group in which intentional exposures were more common than unintentional exposures. This,
then, emphasizes the importance of studying this vulnerable population.6

While the National Survey on Drug Use and Health7 reported that 53% of adolescents
who misused prescription opioids purchased or stole them from a friend or relative, another
35.4% misused their own valid prescriptions. Operative procedures often involve a
significant amount of postoperative pain, which can lead to physicians over-prescribing
opioids and, consequently, to the misuse of opioid medications. Common knee surgery and
anterior cruciate ligament (ACL) repair, which are some of the most frequently needed
surgeries in the adolescent population, both require considerable pain control with recovery
and therefore provide a distinct time in which adolescents can become addicted to opioid
medications.4 Taylor et al4 found that of 100 adolescents who underwent ACL reconstruction
performed by six sports medicine surgeons, the surgeons prescribed, on average, 60
oxycodone (5 mg) tablets per patient. These patients used only 36% of the pills prescribed
and so 64% of excess pills remain unused in the patients’ homes.4 Of concern is the fact that
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sixty-four percent of patients and families did not know how to dispose of the extra opioids
properly, meaning that a significant number of these pills remain accessible and available for
non-prescribed use.4 This data underlines the great opportunity to decrease the number of
opioids available for non-prescription by limiting the number of opioids prescribed after
surgeries.

Both Sheridan et al and Gaither et al examined the number of prescriptions written for
opioid medications in relation to, calls and visits to poison control centers, attempted
suicides, and further illicit drug use within the adolescent community across the United States
and both found a direct relationship.8,9 From 1997 to 2012 there has been 140% increase in
suicide or self-inflicted injury, a 176% increase in hospitalizations for opioid poisonings per
100,000 adolescents, and a 161% increase in poisonings from heroin.9 These findings
highlight the depth of the opioid epidemic in the adolescent community.

The state of Pennsylvania (PA) attempted to mitigate this epidemic by limiting opioid
prescriptions for minors in 2016. Specifically, it enacted PA senate bill 1367 act 125, which
restricts practitioners from prescribing minors more than a seven-day supply of opioids
unless there is a documented medical opinion regarding why the patient needs more. Prior to
this law there was no limit on the number of pills that could be prescribed to minors
postoperatively. Few studies, though, have been done looking at changes in actual provider
practice following enactment of the bill.

The primary aim of this study was to assess changes in prescribing practices for
adolescents that underwent various arthroscopic knee surgeries after the enactment of
Pennsylvania Opioid Prescribing Law Act 125. The average MMEs of opioid prescriptions
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and the total number of opioid pills and NSAID milligram dosages prescribed in 2014 vs
2017 were analyzed.

Changes in provider practices for the years 2014 and 2017 with regard to the use of
regional anesthesia in postoperative arthroscopic knee surgery patients was also evaluated.
More specifically, comparing MMEs of postoperative opioid prescriptions for adolescents
that underwent arthroscopic ACL surgery and received a femoral nerve catheter for
postoperative pain control to those who did not receive a femoral nerve catheter in 2014 vs
2017.

Methods
A retrospective cohort study was conducted of patients aged 13 to 17 who underwent
common arthroscopic knee surgeries from February through September 2014 and from
February through September 2017 at a large Pennsylvania pediatric hospital and its
corresponding satellite sites. Data received was de-identified data from the institution’s data
warehouse, which included type of surgery, date of surgery, all post-operative prescriptions
for the specific patient, and the type of peripheral nerve catheter utilized (if applicable).
Inclusion criteria for this study was as follows: (1) Adolescents between 13 and 17 years of
age and (2) patients undergoing common knee surgeries. Exclusion criteria for this study was
as follows: (1) patients who underwent surgery more than once in the same year and/or
appeared in both 2014 and 2017 data sets, and (2) as well as patients who received
postoperative prescriptions with liquid medications. A total of 267 cases were identified with
155 of them involving the anterior cruciate ligament. In addition, a total of 107 cases
involving ACL surgery utilized femoral nerve catheters.
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Postoperative prescription opioids were standardized to MMEs. NSAIDs were
summed to total milligram dosages. Examples of opioids include (but are not limited to)
Vicodin®, OxyContin®, Percocet®, Demerol®, Dilaudid®, morphine, opium, and codeine.
Prescribed MMEs were determined and analyzed for the included patients for the 2014 and
2017 sample groups. In addition, prescribed MMEs for individuals that underwent any knee
surgery with anterior cruciate ligament (ACL) involvement with or without receiving a
femoral peripheral nerve catheter were investigated.

Results
A post hoc power analysis proved our study was able to achieve an 80.00% power to
reject the null hypothesis of zero effect size when the population effect size is 0.46 and the
significance level (alpha) is 0.050 using a two-sided two-sample method.

The non-parametric Mann-Whitney test was used to compare the total number of
opioid pills prescribed postoperatively, opioid dosage prescribed postoperatively expressed in
MMEs, and total NSAID dosage expressed in milligrams after all common surgical
procedures in the data set. Comparing interquartile ranges (IQR) outlined the statistically
significant decrease in number of opioid pills prescribed postoperatively and MMEs in 2017
(U=11042, p=0.0003) compared to 2014 (U=10991, p=0.0003). The median number of postoperative pills and MMEs prescribed in 2014 was 20 and 225 respectively (IQR: 28-50; IQR:
210-375) compared to 2017 with the same medians of 20 and 225 respectively (IQR: 20-40;
IQR: 150-300) (Table 1). There was a statistically significant increase in NSAID total dosage
in 2017 compared to 2014 (U=5430, p<0.0001). The median dosage of NSAIDs in 2014 was
1200 (IQR: 0-48000) compared to the 2017 median dosage of 48000 (IQR: 24000-72000)
(Table 1).
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When comparing opioid prescribing habits in relation to femoral peripheral nerve
catheters, only surgeries involving the ACL were included in the Mann-Whitney test to
standardize predicted postoperative pain. Results included no statistically significant
difference in the number of opioid pills or mean MMEs prescribed postoperatively between
those who did receive a femoral nerve catheter and those who did not receive a femoral nerve
catheter in 2014. However, there was a statistically significant increase in the number of
opioid pills and MMEs prescribed postoperatively for those who received a femoral nerve
catheter compared to those who did not receive a femoral nerve catheter in 2017. (U=261.5,
p<0.0001; U=261.5, p<0.0001). The median number of opioid pills and MMEs prescribed for
patients who received a femoral nerve catheter in 2017 was 40 and 300 respectively (IQR:
30-40; IQR 225-300) compared to patients without femoral nerve catheters in 2017 with a
median number opioid and MMEs of 27 and 203 respectively (IQR: 20-30; IQR 150-225)
(Table 2). In addition, there was no significant difference in the number of opioid pills or
MMEs in 2017 when compared to 2014 among patients who received nerve catheters. There
was a significant decrease in number of opioid pills and MMEs prescribed postoperatively in
2017 compared to 2014 among patients who did NOT receive a nerve catheter (U=345.5,
p=0.0018; U=345.5, p<0.0002). The median number of opioid pills and MMEs prescribed in
2017 was 27 and 203 respectively (IQR: 20-30; IQR 150-225) compared to 2014 in which the
median number of opioid pills and MMEs prescribed was 33 and 243 respectively (IQR: 2841 IQR: 210-303) (Table 3).

Limitations
Limitations to this study include only collecting data from a single facility, thereby
making results not generalizable to all facilities, weak support for causality, and lack of
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knowledge of possible confounding institutional factors. In addition, there was a small
sample size for 2014 and 2017 ACL surgeries without the use of peripheral nerve catheters
(n=12 & n=36, respectively). Finally, it is difficult to standardized expected pain
postoperatively due to the subjective manner of pain perception. While it was attempted to
standardized pain expectation by choosing the same surgery, pain perception is still highly
individualized.

Discussion
The results of the analysis show that after common knee surgeries, there is a general
trend that physicians are prescribing fewer postoperative opioid pills, lower MMEs, and more
NSAIDs postoperatively in the population of interest when comparing data from 2014 to
2017. This is a promising finding and certainly what would be expected to see following the
enactment of Pennsylvania Opioid Prescribing Law Act 125. However, when looking at how
prescribing habits have changed when initiating multimodal pain control methods such as
peripheral nerve catheters, our results highlight key issues.

The general trends when comparing this surgical population do not hold true. In fact,
in 2017, patients who received femoral peripheral nerve catheters, a procedure done to
decrease postoperative pain, received more postoperative opioid pills and higher average
MMEs than those who did not receive femoral peripheral nerve catheters. Femoral nerve
catheters carry the risk of infection, bleeding, migration of the catheter, and nerve damage.
These risks are very low and there is a consensus that the benefit of superior pain control
outweighs these very rare risks. In fact, Jeng et al10 argued that retrospective studies showed
that the incidence of nerve damage from peripheral nerve blocks were approximately 0.5%1% and the incidence of hematoma formation was 5.7%-6.6% for femoral nerve catheters.
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Infection rates from the same study show that local infection from peripheral nerve catheters
occurred at a rate of 0-3.2%. Bacterial colonization of peripheral nerve catheters, however,
can range from 7.5% to 57% depending on the location of the catheter.10 When utilizing
femoral nerve catheters, patients are typically sent home with the catheter to aid with pain
control for the next 24-72 hours. When using this superior method of pain control, fewer
postoperative opioids and lower average MMEs should be prescribed to decrease opportunity
for excess opioids to enter the community. This is a relatively large oversight and needs to be
addressed.

Conclusions
New multimodal approaches to pain management have the potential to decrease
greatly the number of excess opioids health care providers inadvertently distribute to the
community. This study shows that while utilizing these new approaches, prescribing practices
are not adapting quickly and physicians are prescribing the same number of opioids
postoperatively. Patients are receiving the benefit of superior pain control, but the number of
opioids in the community available for diversion continues to increase. Future research needs
to address driving factors behind this prescribing discrepancy and possible solutions to fix
this problem.

Implications
Future research needs to help determine how prescribers are deciding to change
prescriptive practices after femoral nerve catheters are administered and the appropriate
postoperative dosing adjustments after initiation femoral nerve catheters, as well as how best
to address the attitude prescribers have towards femoral nerve catheters and to educate them
about their benefits. With new and evolving methods of pain control, using multimodal
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approaches to decrease the necessity of opioid usage, providers must make sure postoperative
prescribing practices evolve at the same time.
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Table 1. Prescriptions After All Common Knee Surgeries 2014 Vs. 2017
2014 (n=120)

Median

IQR

2017 (n=147)

Median

U Statistic

P

IQR

All Common Knee Surgeries

MME

225

210

375

225

150

300

10991

0.0003

Number of Opioid Pills

30

28

50

30

20

40

11042

0.0003

NSAIDS

12000

0

48000

48000

24000

72000

5430

<0.0001

Abbreviations: IQR, interquartile ranking; MME, morphine milliequivalent; NSAIDS, nonsteroidal antiinflammatory drugs.

13

Table 2. Postoperative Prescriptions ACL Surgeries With Vs. Without Femoral Peripheral Nerve Catheters 2014 and 2017
2014 (n=72)

U Statistic

No Block (n=12)

Median

P

Block (n=60)

IQR

Median

IQR

ACL
MME

243

210

303

300

210

450

310

0.4409

Number of Opioid Pills

33

28

41

35

28

60

320

0.5336

NSAIDS

0

0

2400

19000

0

48000

293

0.2944

2017 (n=83)

No Block (n=36)

Median

IQR

U Statistic

P

Block (n=47)

Median

IQR

ACL
MME

203

150

225

300

225

300

261.5

<0.0001

Number of Opioid Pills

27

20

30

40

30

40

261.5

<0.0001

NSAIDS

7200

66000

72000

36000

24000

62000

1256

0.0001

Abbreviations: ACL, anterior cruciate ligament; IQR, interquartile ranking; MME, morphine milliequivalent; NSAIDS,
nonsteroidal antiinflammatory drugs.
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Table 3.Postoperative prescriptions ACL surgery With Vs. Without Femoral Peripheral Nerve Catheters 2014 Compared to 2017
2014

Median

2017

IQR

Median

U Statistic

P

IQR

No Block (n=48)

MME

243

210

303

203

150

225

345.5

0.0002

Number of Opioid Pills

33

28

41

27

20

30

345.5

0.0018

NSAIDS

0

0

2400

7200

66000

72000

65.5

0.0001

MME

300

210

450

300

225

300

1426.5

0.9190

Number of Opioid Pills

35

28

60

40

30

40

1388.5

0.8913

NSAIDS

19000

0

48000

36000

24000

62000

930.5

0.0023

Block (n=107)

Abbreviations: ACL, anterior cruciate ligament; IQR, interquartile ranking; MME, morphine milliequivalent; NSAIDS,
nonsteroidal anti-inflammatory drugs.
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